2019
DOI: 10.2478/rjim-2018-0036
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic and bone profile in postmenopausal women with and without type 2 diabetes: a cross-sectional study

Abstract: Introduction. Current studies support the implication of metabolic changes associated with type 2 diabetes in altering bone metabolism, structure and resistance. Objective. We conducted a cross-sectional study on postmenopausal women aimed to analyze the differences in metabolic and bone profile in patients with and without type 2 diabetes Methods. We analyzed the metabolic and bone profile in postmenopausal women with and without type 2 diabetes (T2DM). Clinical, metabolic, hormonal parameters, along with lum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 28 publications
(42 reference statements)
1
6
0
Order By: Relevance
“…In present study the BMI was found to be higher in diabetic group (27.96±4.56) as compared to non-diabetic group (24.45±4.42) (p<0.0001). This is concordance with the study of Dumitru N et al and Nan R et al 15,16 Overweight and obese patients present an increased risk of fracture to minimal trauma. An increased BMI is no longer a protective factor against fragility fractures as it was considered in the past.…”
Section: Discussionsupporting
confidence: 93%
See 4 more Smart Citations
“…In present study the BMI was found to be higher in diabetic group (27.96±4.56) as compared to non-diabetic group (24.45±4.42) (p<0.0001). This is concordance with the study of Dumitru N et al and Nan R et al 15,16 Overweight and obese patients present an increased risk of fracture to minimal trauma. An increased BMI is no longer a protective factor against fragility fractures as it was considered in the past.…”
Section: Discussionsupporting
confidence: 93%
“…The inhibition of bone formation in T2DM may be due to the accumulation of advanced glycation end-products (AGEs) in the organic bone matrix, which may interfere with normal osteoblast function. 18 [15][16][17]22,23 Lower osteocalcin and P1NP levels found in this study suggest slower bone metabolism with reduced bone formation in postmenopausal type 2 diabetes women as compared to non-T2DM healthy controls. The inhibition of bone formation in T2DM may be due to the accumulation of advanced glycation end-products (AGEs) in the organic bone matrix, which may interfere with normal osteoblast function.…”
Section: Discussionmentioning
confidence: 73%
See 3 more Smart Citations